Bioservo Technologies AB publishes prospectus

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, WITHIN OR INTO THE RUSSIAN FEDERATION, BELARUS, AUSTRALIA, HONGKONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE CONTRAVENING TO ANY APPLICABLE RULES. ADDITIONAL RESTRICTIONS ARE APPLICABLE, PLEASE SEE “IMPORTANT INFORMATION” IN THE END OF THIS PRESS RELEASE.

Bioservo Technologies Aktiebolag ("Bioservo" or the "Company") is today publishing a prospectus which has been approved and registered with the Swedish Financial Supervisory Authority (Finansinspektionen) due to the upcoming share issue. The prospectus is available on Bioservo's website (www.bioservo.com) and Erik Penser Bank's website (www.penser.se).

The subscription period for the new issue begins on September 26, 2022.

Advisor
Erik Penser Bank AB is financial advisor to Bioservo in connection with the share issue and Born Advokater is legal advisor.

For more information, please contact
Petter Bäckgren, CEO Bioservo
Email: petter.backgren@bioservo.com

Important information
This press release is not an offer to subscribe for units in Bioservo Technologies Aktiebolag (publ) and investors should not subscribe or acquire any securities other than on the basis of the information in the prospectus.

This press release may not be published, published or distributed, directly or indirectly, in or to the United States, Australia, Japan or Canada or in any other jurisdiction where the distribution of this press release would be illegal. Nor does this press release constitute an offer to sell new units, BTUs or unit rights to any person in a jurisdiction where it would not be permitted to make such an offer to such person or where such action would require additional prospectus, registration or other measures than under Swedish law. The prospectus, the registration form and other documents relating to the Rights Issue may not be distributed in or to any country where such distribution or the Rights Issue requires measures as stated in the preceding sentence or where they would be contrary to regulations in such country.

The New Shares, BTUs and Unit Rights have not been recommended or approved by any US federal or state securities or regulatory authority. No new shares, BTUs, unit rights or other securities issued by Bioservo Technologies Aktiebolag have been registered or will be registered under the United States Securities Act of 1933 from time to time, or under the securities laws of any state in the United States. Therefore, no new shares, BTUs, subscription rights or other securities issued by the Company may be transferred, used or offered for sale in the United States except in such exceptional cases that do not require registration or through a transaction that is not covered by such registration. There is no intention to register any part of the offering in the United States and the securities issued in the Rights Offering will not be offered to the public in the United States.

The company has not approved any offer to the public regarding the securities referred to in this press release in any other country within the European Economic Area ("EEA") other than Sweden. In other member states of the EEA, the securities can therefore only be offered to qualified investors.

This press release may only be distributed in the United Kingdom and is directed only to "qualified investors" (as defined in section 86(7) of the Financial Services and Markets Act 2000) who are (i) professional investors covered by section 19(5) of Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 ("Order"), or (ii) persons covered by section 49(2)(a) to (d) ("high net worth companies" etc.) of the Order (collectively referred to as "relevant persons"). In the United Kingdom, such investment or other investment activity referred to in this press release is only available to, and is directed to, relevant persons only. Any person who is not a relevant person should not act on or rely on this notice or any of its contents.